Company news

OnKure Therapeutics, Inc. news in 2024

OnKure Therapeutics, Inc.'s news releases, calls and decks from 2024, newest first.

View company

OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic Data from its First-In-Human PIKture-01 Trial of OKI-219

December 11, 2024

OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219

December 9, 2024

OnKure Announces New Date for Upcoming Investor Call

November 25, 2024

OnKure Therapeutics: INDEX TO UNAUDITED CONDENSED FINANCIAL STATEMENTS Form 8 K

November 7, 2024

OnKure to Present at the Stifel 2024 Healthcare Conference

November 5, 2024

OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium

October 31, 2024

ONKE THERPAR: Report of Independent Registered Public Accounting Firm Form 8 K

October 8, 2024

OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million

October 3, 2024

Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure

October 2, 2024

Decks in 2024